Publication | Open Access
Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER)
21
Citations
22
References
2021
Year
We observed no significant effect of sofosbuvir/daclatasvir versus placebo on hospital discharge or survival in hospitalized COVID-19 patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1